Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat PTSD
Status:
Active, not recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
This is a small, open-label treatment study that tests the potential safety and treatment
effectiveness of a stellate ganglion block combined with Massed Prolonged Exposure (PE). Each
of the 12 participants will receive ten 90-minute sessions of Massed Prolonged Exposure and
an injection of a stellate ganglion block between the first and second PE sessions.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio